MichaelRichardRobinsonMD

Physician

Dr. Robinson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
200 Pacific Coast Hwy
Huntington Beach, CA 92648
Phone+1 949-419-5928

PubMed

6 citations
Safety and Efficacy of Twice-Daily Pilocarpine HCl in Presbyopia: The Virgo Phase 3, Randomized, Double-Masked, Controlled Study.
Shane Kannarr, Sherif M El-Harazi, Majid Moshirfar, Christopher Lievens, Jennifer Lee Kim
American Journal of Ophthalmology. 2023-09-01
16 citations
Safety and Efficacy of AGN-190584 in Individuals With Presbyopia: The GEMINI 1 Phase 3 Randomized Clinical Trial.
George O Waring 4th, Francis W Price Jr, David Wirta, Cathleen McCabe, Majid Moshirfar
JAMA Ophthalmology. 2022-04-01
4 citations
In Vitro and In-Eye Comparison of Commercial Pilocarpine Ophthalmic Solution and an Optimized, Reformulated Pilocarpine for Presbyopia Treatment.
Mitchell A Jackson, Jaya Giyanani, Yumna Shabaik, Jeff Penzner, Anuradha V Gore
Ophthalmology and Therapy. 2022-04-01

Positive Results for Twice Daily Presbyopia Eye DropsApril 6th, 2022
REGENXBIO Announces Initiation of Second Pivotal Trial in RGX-314 Clinical Program for the Treatment of Wet AMD Using Subretinal DeliveryJanuary 10th, 2022
Growing Number of Devices Set to Transform Glaucoma TreatmentJuly 15th, 2017
Join now to see all